Literature DB >> 11867073

Castleman's disease-associated neuropathy: no evidence of human herpesvirus type 8 infection.

L Zumo1, R P Grewal.   

Abstract

Castleman's disease (CD) is a rare lymphoproliferative disorder that may be associated with a neuropathy. In a recent report, the presence of human herpesvirus type 8 (HHV-8) DNA sequences were detected in an HIV-negative patient with polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) associated with the multicentric hyaline vascular variant of CD. It was proposed that the presence of these sequences may have a role in the pathophysiology of the neuropathy. We describe an HIV-negative woman with the multicentric plasma cell form of CD who presented with a disabling neuropathy. In addition to a severe demyelinating polyneuropathy, she had some of the other features of POEMS including an IgA lambda gammopathy and lymphadenopathy. We were unable to detect the presence of either HHV-8 DNA or proteins in this patient. The significance of our results and the relationship between CD, POEMS and neuropathy are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867073     DOI: 10.1016/s0022-510x(01)00679-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Castleman's disease of the neck: report of 4 cases with unusual presentations.

Authors:  Lei Jiang; Liang Yu Zhao; Yuan Liu; Yun Fu Zhao
Journal:  J Oral Maxillofac Surg       Date:  2010-08-12       Impact factor: 1.895

2.  Optic neuropathy associated with Castleman disease.

Authors:  Ungsoo Kim; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2010-08-03

3.  Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo.

Authors:  Gianna Ballon; Gunkut Akar; Ethel Cesarman
Journal:  PLoS Pathog       Date:  2015-01-21       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.